Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of October—and that an FDA application could soon follow. But more than 60 researchers and bioethicists urged the partners to wait for more safety data before submitting their shot for a green light, Bloomberg reports. The experts called on… Read More »
Pharmaceutical company AstraZeneca will put an experimental coronavirus vaccine study on hold in America after a participant in the United Kingdom faced an apparent serious adverse reaction, according to a report. The Anglo-Swedish company’s “standard review process triggered a pause to vaccination to allow review of safety data,” an AstraZeneca spokesperson said. CORONAVIRUS: WHAT YOU NEED TO KNOW… Read More »
According to a study carried out by Lloyds Pharmacy 46% of Irish adults said they are planning on getting the flu vaccine this year. Research shows, 74 per cent of adults claim that the COVID-19 pandemic has made them more aware of the importance of being vaccinated against viruses. However, 46 per cent of adults… Read More »
New experimental coronavirus vaccine prevented severe disease in mice after two doses of the jab boosted their antibody levels 90-fold Researchers genetically modified vesicular stomatitis virus (VSV), which causes a mild illness in livestock, to become a vaccine The team took out a gene from VSV and inserted the spike protein from the coronavirus, which… Read More »